Emily Chen Selected Research

Emily Chen Research Topics

Disease

9	Neoplasms (Cancer) 11/2020 - 08/2005
6	COVID-19 01/2022 - 12/2020
6	Infections 01/2022 - 06/2011
6	Neoplasm Metastasis (Metastasis) 11/2012 - 04/2011
5	Syndrome (Syndromes) 11/2012 - 12/2011
3	Pain (Aches) 12/2021 - 04/2012
3	Fibrosis (Cirrhosis) 01/2019 - 01/2017
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2017
2	Insulin Resistance 01/2019 - 01/2018
2	Disease Progression 10/2018 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 01/2017
2	Chronic Disease (Chronic Diseases) 05/2013 - 10/2012
2	Brain Neoplasms (Brain Tumor) 09/2012 - 07/2012
1	Blister (Bulla) 06/2022
1	Foreign Bodies (Foreign Body) 06/2022
1	Glaucoma 06/2022
1	Postoperative Pain 12/2021
1	Hypersensitivity (Allergy) 12/2021
1	Leukemia 05/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2021
1	Atopic Dermatitis (Atopic Eczema) 04/2021
1	Paralysis (Palsy) 01/2021
1	Oligodendroglioma 01/2021
1	Incisional Hernia 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 11/2020
1	Adenocarcinoma 11/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Carcinogenesis 09/2020
1	Neglected Diseases 03/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Central Nervous System Infections (Central Nervous System Infection) 12/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019
1	Diabetes Mellitus 01/2019
1	Multiple Sclerosis 01/2019
1	Weight Gain 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Cryptosporidiosis 10/2018
1	Obesity 01/2018
1	Inflammation (Inflammations) 01/2018
1	Penile Neoplasms (Penile Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2005
5	Pharmaceutical PreparationsIBA 01/2021 - 03/2005
3	VaccinesIBA 01/2022 - 06/2011
3	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2021
2	CeramidesIBA 04/2021 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 02/2021 - 03/2005
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 09/2020
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2018 - 08/2003
2	LipidsIBA 01/2017 - 11/2016
1	Secretory Leukocyte Peptidase InhibitorIBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	SerpinsIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Antithrombin IIIIBA 01/2022
1	Antivenins (Antivenoms)IBA 12/2021
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 12/2021
1	Opioid Analgesics (Opioids)IBA 12/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2021
1	ChromatinIBA 05/2021
1	molnupiravirIBA 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	LigandsIBA 11/2020
1	Protein Isoforms (Isoforms)IBA 11/2020
1	MicroRNAs (MicroRNA)IBA 09/2020
1	benzonidazole (benznidazole)IBA 03/2020
1	GDC-0084IBA 12/2019
1	lestaurtinibIBA 12/2019
1	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 12/2019
1	PanobinostatIBA 12/2019
1	Plicamycin FDA Link 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	ChitinasesIBA 01/2019
1	EnzymesIBA 01/2019
1	pyrimidineIBA 01/2019
1	NucleosidesIBA 01/2019
1	purineIBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2019
1	BilirubinIBA 10/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018
1	1- palmityl- 2- (4- carboxybutyl)- sn- glycero- 3- phosphocholineIBA 10/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2018
1	Factor Xa (Coagulation Factor Xa)IBA 01/2018
1	Caveolin 1IBA 01/2018
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2018

Therapy/Procedure

11	Radiotherapy 01/2021 - 04/2011
9	Therapeutics 12/2020 - 11/2008
4	Palliative Care (Palliative Therapy) 05/2013 - 04/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2018
2	Liver Transplantation 01/2019 - 10/2018
2	Pain Management 11/2015 - 12/2012
1	Lasers (Laser) 06/2022
1	Excimer Lasers 06/2022
1	Laparotomy 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Bed Rest (Bedrest) 01/2020
1	Off-Label Use 01/2019